CN104703611B - 用于生产免疫调节剂的多阶段方法 - Google Patents

用于生产免疫调节剂的多阶段方法 Download PDF

Info

Publication number
CN104703611B
CN104703611B CN201380035496.XA CN201380035496A CN104703611B CN 104703611 B CN104703611 B CN 104703611B CN 201380035496 A CN201380035496 A CN 201380035496A CN 104703611 B CN104703611 B CN 104703611B
Authority
CN
China
Prior art keywords
growth medium
euglena
method described
bioreactor
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201380035496.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN104703611A (zh
Inventor
罗伯特·伯纳德·莱文
杰弗里·理查德·勒布伦
杰弗里·保罗·霍斯特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jianming Michigan Co ltd
Kemin Industries Inc
Original Assignee
Ai Erge Scientific & Technical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ai Erge Scientific & Technical Corp filed Critical Ai Erge Scientific & Technical Corp
Publication of CN104703611A publication Critical patent/CN104703611A/zh
Application granted granted Critical
Publication of CN104703611B publication Critical patent/CN104703611B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L17/00Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
    • A23L17/60Edible seaweed
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0003General processes for their isolation or fractionation, e.g. purification or extraction from biomass
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/10Protozoa; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/12Unicellular algae; Culture media therefor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Sustainable Development (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Botany (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
CN201380035496.XA 2012-05-07 2013-05-07 用于生产免疫调节剂的多阶段方法 Active CN104703611B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261643572P 2012-05-07 2012-05-07
US61/643,572 2012-05-07
PCT/US2013/039939 WO2013169768A1 (en) 2012-05-07 2013-05-07 Multi-stage process for production of immune modulator

Publications (2)

Publication Number Publication Date
CN104703611A CN104703611A (zh) 2015-06-10
CN104703611B true CN104703611B (zh) 2018-05-18

Family

ID=49549117

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380035496.XA Active CN104703611B (zh) 2012-05-07 2013-05-07 用于生产免疫调节剂的多阶段方法

Country Status (10)

Country Link
US (1) US9574217B2 (https=)
EP (1) EP2858652B1 (https=)
CN (1) CN104703611B (https=)
BR (1) BR112014027989A2 (https=)
CA (1) CA2873026C (https=)
ES (1) ES2743428T3 (https=)
IN (1) IN2014DN09956A (https=)
MX (1) MX362256B (https=)
PL (1) PL2858652T3 (https=)
WO (1) WO2013169768A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX363063B (es) 2013-03-14 2019-03-06 Algal Scient Corporation Modulacion de la funcion del sistema inmunitario de las plantas.
WO2015099817A1 (en) * 2013-12-26 2015-07-02 Algal Scientific Corporation Method for improving feed efficiency and increasing growth rates in animals
US10456433B2 (en) * 2015-04-08 2019-10-29 Euglena Co., Ltd. Suppressive agent for rheumatoid arthritis, prophylactic agent for rheumatoid arthritis, therapeutic agent for rheumatoid arthritis, and food for suppressing rheumatoid arthritis
WO2017075262A1 (en) 2015-10-28 2017-05-04 Algal Scientific Corporation Use of beta-1,3-glucan for modulating immune function and treating intestinal inflammation
US20170290853A1 (en) * 2016-04-12 2017-10-12 Kemin Industries, Inc. Methods to facilitate the solubilization of beta-1,3-glucan and enhance immune function and other related uses
CN105942310A (zh) * 2016-04-28 2016-09-21 北京珍生康业生物科技有限公司 一种破膜裸藻干粉的制备方法
US20180168190A1 (en) * 2016-06-09 2018-06-21 Algaeon, Inc. Euglena derived animal feed composition
US20180169161A1 (en) * 2016-06-09 2018-06-21 Algaeon, Inc. Euglena derived composition having immune response inducing components
JP2019523654A (ja) * 2016-06-09 2019-08-29 エフ3 プラットフォーム・バイオロジクス,インコーポレーテッド ユーグレナ溶解産物組成物ならびに該組成物および精製されたベータ−1,3−グルカンを生産するための方法
US9901606B2 (en) * 2016-06-09 2018-02-27 Algaeon, Inc. Euglena lysate composition
US20180280450A1 (en) * 2017-03-28 2018-10-04 Kemin Industries, Inc. Method of promoting immune health using the water-soluble component from genus euglena organism
US20190167738A1 (en) * 2017-12-01 2019-06-06 Kemin Industries, Inc. Compositions containing euglena gracilis for viral protection and related methods
WO2019160599A1 (en) * 2018-02-19 2019-08-22 F3 Platform Biologics, Inc. Euglena derived composition, including animal feed composition
EP3990619A4 (en) * 2019-06-28 2024-07-03 Noblegen Inc. Methods of optimized euglena fermentation using engineered tank design
KR102083165B1 (ko) * 2019-09-18 2020-03-02 대상 주식회사 베타-1,3-글루칸 생산능을 갖는 신규의 유글레나 속 균주 및 이를 이용한 베타-1,3-글루칸을 함유하는 유글레나 균체의 제조방법

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101979498A (zh) * 2010-12-01 2011-02-23 华东理工大学 一种微藻高产率异养培养的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2725677A (en) 1952-01-16 1955-12-06 Carnegie Inst Of Washington Method of effectuating high density mass culture of algae or other microorganisms
JPH0671430B2 (ja) * 1986-09-11 1994-09-14 大阪瓦斯株式会社 ユ−グレナ細胞によるβ−1,3−グルカンの製造方法
JP2516031B2 (ja) * 1987-09-14 1996-07-10 ハリマ化成株式会社 稚仔魚用餌料
US5272261A (en) 1989-01-11 1993-12-21 Merrell Dow Pharmaceuticals Inc. Preparation of sulfated polysaccharide fractions
US5084386A (en) * 1989-03-31 1992-01-28 Sri International Production of beta-1,3-glucan in euglena
JP2777418B2 (ja) * 1989-09-13 1998-07-16 雪印乳業株式会社 ユーグレナの培養方法とその装置
US5385382A (en) 1993-10-06 1995-01-31 Ford Motor Company Combination seat frame and ventilation apparatus
EP1029892B1 (de) 1999-02-10 2002-06-05 Dr. Suwelack Skin & Health Care AG Beta-1,3-Glucan aus Euglena enthaltendes gefriergetrocknetes Erzeugnis, seine Herstellung und Verwendung
WO2004030613A2 (en) 2002-09-04 2004-04-15 University Of Louisville Research Foundation, Inc. Cancer therapy using beta glucan and antibodies
JP5731982B2 (ja) 2008-10-14 2015-06-10 ソラザイム, インコーポレイテッドSolazyme Inc 微細藻類バイオマスの食物組成物
US20100303989A1 (en) * 2008-10-14 2010-12-02 Solazyme, Inc. Microalgal Flour

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101979498A (zh) * 2010-12-01 2011-02-23 华东理工大学 一种微藻高产率异养培养的方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Increased synthesis of α-tocopherol, paramylon and tyrosine by Euglena gracilis under conditions of high biomass production;J.S. Rodríguez-Zavala等;《Journal of Applied Microbiology》;20101231;第109卷(第6期);2160–2172 *
Paramylon (beta-1,3-glucan) content in wild type and WZSL mutant of Euglena gracilis. Effects of growth conditions;Laura Barsanti等;《Journal of Applied Phycology》;20011231;第13卷;说明书摘要,图1、图2,第63页右栏第1-2段 *
Production of paramylon, a β-1,3-glucan, by heterotrophic growth of Euglena gracilis on potato liquor in fed-batch and repeated-batch mode of cultivation;Bozˇidar Šantek等;《Engineering in Life Sciences》;20120229;第12卷(第1期);89–94 *

Also Published As

Publication number Publication date
PL2858652T3 (pl) 2020-01-31
MX362256B (es) 2019-01-09
US9574217B2 (en) 2017-02-21
US20130303752A1 (en) 2013-11-14
CA2873026A1 (en) 2013-11-14
MX2014013553A (es) 2015-07-14
EP2858652A4 (en) 2016-04-27
EP2858652A1 (en) 2015-04-15
CA2873026C (en) 2021-01-12
IN2014DN09956A (https=) 2015-08-14
WO2013169768A1 (en) 2013-11-14
BR112014027989A2 (pt) 2017-07-18
CN104703611A (zh) 2015-06-10
ES2743428T3 (es) 2020-02-19
EP2858652B1 (en) 2019-07-10

Similar Documents

Publication Publication Date Title
CN104703611B (zh) 用于生产免疫调节剂的多阶段方法
AU2016344136B2 (en) Use of beta-1,3-glucan for modulating immune function and treating intestinal inflammation
JP5829917B2 (ja) 粘土をインターレースした酵母組成物およびそれを利用する方法
Cano-Lozano et al. Probiotics in tilapia (Oreochromis niloticus) culture: Potential probiotic Lactococcus lactis culture conditions
CN105849242A (zh) 从微生物中回收油的方法
JP2020501547A (ja) バイオマス材料からの核酸及びそのフラグメントの除去
US20170290853A1 (en) Methods to facilitate the solubilization of beta-1,3-glucan and enhance immune function and other related uses
AU2017277413B2 (en) Euglena lysate composition and method for producing the composition and a purified beta-1,3-glucan
Kuntsova et al. Obtaining yeast mannoproteins with antimicrobial properties
Bhagea et al. Microalgae as sources of green bioactives for health-enhancing food supplements and nutraceuticals: A review of literature
CN106604998B (zh) 重复补料分批培养方法
US9901606B2 (en) Euglena lysate composition
US20170356020A1 (en) Method of forming a purified beta-1,3,-glucan
Singh et al. Cyanobacteria as natural biofactories
CN1203167C (zh) 深海远古生物基因免疫调控酒的生产方法
RU2849073C1 (ru) Способ получения биологически активных лизатов дрожжей с комплексным иммуномодулирующим, детоксикационным действием и нутритивной поддержкой
CN113768037B (zh) 一种高gm比的瓜尔豆胶酶解产物的制备方法
KR20130015037A (ko) 미세녹조류를 이용한 항염증 및 항여드름효능을 가지는 추출물 및 그의 제조방법
WO2025159694A1 (en) Macroalgal fermentation for the production of vitamin k2
CN117645648A (zh) 一种金枪鱼鱼卵糖蛋白的制备方法及其应用
US20170354698A1 (en) Method of producing a euglena lysate
BR102021010052A2 (pt) Processo para obtenção de extratos promotores do crescimento microbiano de origem vegetal e de origem microbiana, extratos promotores do crescimento microbiano, processo para obtenção de biomassa de microrganismos fotossintetizantes, biomassa de microrganismos fotossintetizantes, e usos da biomassa de microrganismos fotossintetizantes
HK1262257A1 (en) Euglena lysate composition and method for producing the composition and a purified beta-1,3-glucan
Muhammad Saeed et al. Single cell proteins: a novel value added food product.
UA50555A (uk) Штам halobacterium halobium 353п - продуцент білково-вітамінної біомаси

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20200908

Address after: Iowa, USA

Patentee after: Jianming Michigan Co.,Ltd.

Address before: michigan

Patentee before: ALGAL SCIENTIFIC Corp.

Effective date of registration: 20200908

Address after: Iowa, USA

Patentee after: KEMIN INDUSTRIES, Inc.

Address before: Iowa, USA

Patentee before: Jianming Michigan Co.,Ltd.

TR01 Transfer of patent right